NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/19/2025
Back to search
Official data from USPTO
ACCREDO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ACCREDO
ST13
US500000087871539Class
9, 35, 41, 44
Filing
87871539
Registration
5760777
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
09/20/2025
Trademark type
Word
Nice classes
9, 35, 41, 44
Filing date
04/10/2018
Registration date
05/28/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/19/2025
Last transaction
09/20/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
2009-01-00
First use in commerce
2009-01-00
Drawing code
4
Owner type
03
Owner location
St. Louis, MO
Examiner
HOPKINS II, DEAN
Current location
Historical data usage
Holders and representatives
Holders
Express Scripts Strategic Development, Inc.
Representatives
Troy E. Larson
Technical classification
Nice Classes
Class 9Class 35Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
resources appropriate for support of disease managementnamely downloadable electronic publications in the nature of brochuresbooklets and newsletters related to the support of disease management
Class 35
mail order pharmacy services specializing in the treatment and control of chronic diseases and specialty medications; mail order pharmacy services specializing in the control of hemophilia
Class 41
Providing patient educational servicesconducting programs in the field of chronic diseases and specialty medicationsdistributing course materials in connection therewith and providing patient educational servicesconducting programs in the field of proper product-reconstitution and administration; providing resources appropriate for support of disease managementproviding a website featuring non-downloadable publications in the nature of brochures and newsletters related to the support of disease management; providing a website featuring non-downloadable videos related to the support of disease management; educational services for product manufacturerspharmaceutical clinicians and biotech companiesclinicianscontract research organizations and insurance providersconducting classesone-on-one sessions and telephonic workshops in the field of clinical education and distributing course materials in connection therewith; educational servicesclassesone on one sessions and telephonic workshops which provide physiciansinsurance companies and patients with specific characteristics associated with disease management products; educational services and resourcesconducting workshops for children to help them understand hemophilia; educational servicesconducting workshops for children to help them understand hemophilia and other chronic conditions and diseases
Class 44
Nursing care specializing in the treatmentprevention and control of chronic diseasesnursing care services related to specialty medications; nursing care specializing in the treatmentprevention and control of hemophilia; medical servicesadministration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophilia; administration of pharmaceutical preparations used in the treatment of chronic diseases; nursing and pharmacy care servicesdisease management services; telephone hotline counselingoffering healthcare advice; services consisting of providing nutritional guidance and consultation to chronically ill patients; providing educational information about nursing and pharmacy care servicesproviding resources appropriate for support of disease management
Publications
History of USPTO decisions and trademark events.
35 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/19/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/19/2025
E815
TEAS SECTION 8 & 15 RECEIVED
05/08/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/25/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/25/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/25/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/28/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/04/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
05/28/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/12/2019
PUBO
PUBLISHED FOR OPPOSITION
03/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/20/2019
ALIE
ASSIGNED TO LIE
02/01/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/17/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
01/17/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/17/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
01/17/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/17/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/16/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/15/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/15/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/04/2018
GNFR
FINAL REFUSAL E-MAILED
09/04/2018
CNFR
FINAL REFUSAL WRITTEN
09/04/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/24/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/23/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/23/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/30/2018
GNRT
NON-FINAL ACTION E-MAILED
04/30/2018
CNRT
NON-FINAL ACTION WRITTEN
04/30/2018
DOCK
ASSIGNED TO EXAMINER
04/27/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/19/2018
NWAP
NEW APPLICATION ENTERED
04/13/2018
Continuous trademark protection
Get notified about every new filing that threatens ACCREDO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.